Table 5. Nine patients with additional respiratory viruses detected only in their saliva for the second cohort of patients.

Case Number	Sex/age in years	Underlying medical conditions	Presenting symptom; final diagnosis	Respiratory virus detected in NPAa	Additional virus detected in salivaa	Potential changes in antiviral treatment or infection control practice
1	M/56	Nasopharyngeal carcinoma	Productive cough, dyspnea; pneumonia	Negativeb	Influenza A H1	Neuraminidase inhibitor
2	F/78	Gout	Fever, dyspnea; lower respiratory tract infection	Negativeb	Influenza A H3	Neuraminidase inhibitor
3	M/81	DM, Ca prostate	Productive cough; upper respiratory tract infection	Negativec	Influenza A H3	Neuraminidase inhibitor
4	F/81	Hypertension, hyperlipidemia, IFG	Rhinorrhea, cough, dyspnea, wheeze; pneumonia	EV/RVb	hMPV	Contact precaution
5	M/72	DM, hypertension	Fever, rhinorrhea, dry cough; pneumonia	Negativeb	hMPV	Contact precaution
6	M/55	Schizophrenia, gout, CVA	Fever, productive cough; pneumonia	Negativec	hMPV	Contact precaution
7	M/63	Asthma, Churg-Strauss syndrome	Productive cough, dyspnea; asthmatic attack	Negativeb	EV/RV	Nil
8	F/63	Stage IV lymphoma, hypertension, asthma	Fever, productive cough, chills; upper respiratory tract infection	Negativeb	EV/RV	Nil
9	M/79	Ischemic heart disease, diabetic nephropathy, Ca prostate with bone metastasis, pemphigoid, bronchiectasis	Fever and dizziness; CAPD peritonitis	Negativec	Coronavirus OC43	Nil

Abbreviations: carcinoma, Ca; continuous ambulatory peritoneal dialysis, CAPD; cerebrovascular accident, CVA; diabetes mellitus, DM; enterovirus/rhinovirus, EV/RV; human metapneumovirus, hMPV; impaired fasting glucose, IFG.

^aRespiratory virus detection was performed using NxTAG Respiratory Pathogen Panel.

^bSufficient nasopharyngeal columnar epithelial cells detected during DFA.

^cInsufficient nasopharyngeal columnar epithelial cells detected during DFA.